ArticleFrontiers in immunology2022

The Chemokine Receptor CCR8 Is a Target of Chimeric Antigen T Cells for Treating T Cell Malignancies.

Diwei Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.